- Country: Brazil
- Summary: Acquisition of Oncological Medications Ii (Process: 25410.011195/2023-17
- BRT Ref No: 95005001
- Deadline: 23 Jan 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 90003/2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Object: Electronic Auction - Acquisition of Oncological Medicines II (Process: 25410.011195/2023-17
UASG Code: 250052
Notice from: 01/10/2024 from 09:00 to 16:00
Proposal Delivery: a from 01/10/2024 at 09:00
CYCLOSPORIN, CONCENTRATION 100 MG
Quantity: 16300
CYCLOSPORIN19981d172c851bd4e8a1788d5726c2d3A, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM ORAL SOLUTION
Quantity: 90
CISPLATIN, CONCENTRATION 50 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION
Quantity: 10624
CYTARABINE, HYCLORHYDRATE COMPOSITION, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM SOLUTION IN JETABLE
Quantity: 6394
DACARBAZINE, CONC19981d172c851bd4e8a1788d5726c2d3INJECTION 200 MG, INJECTABLE USE
Quantity: 4412
DACARBAZINE, CONCENTRATION 200 MG, INJECTABLE USE
Quantity: 1469
DAUNORUBICIN, DOSAGE 20 MG, INJECTABLE PRESENTATION
Quantity: 2058
DECITABINE, CONCENTRATION 50 MG, PHARMAC FORM EUTICA LYOPHIL POWDER FOR INJECTION
Quantity: 300
DOCETAXEL, CONCENTRATION19981d172c851bd4e8a1788d5726c2d3NO 20 MG/ML, INJECTABLE PHARMACEUTICAL FORM
Quantity: 9596
DOCETAXEL, CONCENTRATION 40 MG/ML, INJECTABLE PHARMACEUTICAL FORM
Quantity: 10370
DOXORUBICIN HClORHYDRATE, DOSAGE 50 MG, INJECTABLE INDICATION
Quantity: 290
DOXORUBI CINA CHLORIDrate, DOSAGE 50 MG , INJECTABLE INDICATION
Quantity: 12102
19981d172c851bd4e8a1788d5726c2d3ETOPOSIDE, CONCENTRATION 20 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 7390
ETOPOSIDE, CONCENTRATION 20 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 2463
DASATINIB, CONCENTRATION 20 MG
Quantity: 8100
DASATINIB, CONC INPUT 100 MG
Quantity : 8050
G1
Quantity :19981d172c851bd4e8a1788d5726c2d3 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAcquisition of Oncological Medications Ii (Process: 25410.011195/2023-17 - Brazil Tender
The MINISTRY OF HEALTH, a Government sector organization in Brazil, has announced a new tender for Acquisition of Oncological Medications Ii (Process: 25410.011195/2023-17. This tender is published on BrazilTenders under BRT Ref No: 95005001 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-01-23.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
